Company intelligence / Profile preview
Nanjing Huanglong Biotechnology
Nanjing, Jiangsu, Chinahuanglongbio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Nanjing Huanglong Biotechnology develops and produces small molecule chemical drugs, focusing on generics for special diseases and progressive imitation drugs with clinical value. The company leverages its parent’s resources to bring overseas off-patent drugs to China and replace imports with domestic alternatives. It has over 100 registered products but does not publicly disclose detailed clinical results.
- Therapeutic areas
- Rare DiseasesOther
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Nanjing Huanglong Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nanjing Huanglong Biotechnology.